Table 4: Distribution of clinical features for first generation studies by type of analysis
| Type of analysis | Baseline feature | Comparator 1 | Comparator 2 | Proportion of baseline feature in comparator 1 (%) | Proportion of baseline feature in comparator 2 | ||||||
| Number of iStents-reduction in IOP | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/999 (4.5%) | iStent alone: 90/287 (31.4%) | ||||||
| Number of iStents-preoperative IOP | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/999 (4.5%) | iStent alone: 90/240 (37.5%) | ||||||
| Number of iStents-postoperative IOP | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/882 (5.1%) | iStent alone: 90/240 (37.5%) | ||||||
| Number of iStents-reduction in medications | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/999 (4.5%) | iStent alone: 90/287 (31.4%) | ||||||
| Number of iStents-preoperative medications | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/999 (4.5%) | iStent alone: 90/336 (26.8%) | ||||||
| Number of iStents- postoperative medications | Phacoemulsification status | One iStent | Two iStents | iStent alone: 45/999 (4.5%) | iStent alone: 90/336 (26.8%) | ||||||
| Number of iStents-reduction in IOP | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/999 (4.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents-preoperative IOP | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/999 (4.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents-postoperative IOP | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/882 (5.1%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents-reduction in medications | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/999 (4.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents-preoperative medications | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/999 (4.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents - postoperative medications | Phacoemulsification status | One iStent | Three iStents | iStent alone: 45/999 (4.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents -reduction in IOP | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/287 (31.4%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents -preoperative IOP | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/240 (37.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents -postoperative IOP | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/240 (37.5%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents -reduction in medications | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/287 (31.4%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents -preoperative medications | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/336 (26.8%) | iStent alone: 38/63 (60.3%) | ||||||
| Number of iStents - postoperative medications | Phacoemulsification status | Two iStents | Three iStents | iStent alone: 90/336 (26.8%) | iStent alone: 38/63 (60.3%) | ||||||
| Phacoemulsification status - IOP reduction | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 901/1123 (80.2%) | ||||||
| Phacoemulsification status - preoperative IOP | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 901/1076 (83.7%) | ||||||
| Phacoemulsification status - postoperative IOP | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 784/959 (81.8%) | ||||||
| Phacoemulsification status - reduction in medications | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 901/1123 (80.2%) | ||||||
| Phacoemulsification status -preoperative medications | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 901/1172 (76.9%) | ||||||
| Phacoemulsification status -postoperative medications | Number of iStents | iStent alone | Phaco-iStent | One iStent: 45/173 (26.0%) | One iStent: 901/1172 (76.9%) |
IOP = intraocular pressure.